IFC will get slice of latenight

'Human Centipede: Full Sequence' literally out-grosses the initial. It ain't no "Paranormal Activity," but IFC's continuation from the "Human Centipede" franchise, "Full Sequence," certainly scared its great amount of auds opening weekend -- a minimum of for any limited latenight release from the non-studio entity."Full Sequence," which tested limited to latenight shows on Friday and Saturday, made $49,456 from the total 18 locations, for any solid $2,748 per-screen average, selling out night time tests in NY and La while attractive to hardcore horror fans in addition to fanatics from the original. The very first film, whilst not an enormous B.O. success -- cuming only $181,467 locally -- nonetheless gained head lines and cult status because of its gross-out story. "Full Sequence" focuses on a disturbed fan from the original "Centipede" who tries to re-create that film's grotesque biological procedure.IFC released the film theatrically via its genre label IFC Night time, by having an added video-on-demand component March. 12. The distrib depended heavily on person to person along with a grassroots advertising campaign -- along with the cult status from the first film."Full Sequence" will expand into other Stateside marketplaces throughout October, and really should continue doing well latenight. IFC hopes the pic can build buzz prior to Halloween, though its following might be restricted to indie auds, as greater profile scarers (i.e. "Paranormal Activity 3") also launch mid-October. "Paranormal 3," which bows March. 21, should dominate the pre-Halloween marketplace the vacation itself typically is not a large moviegoing weekend. Contact Andrew Stewart at andrew.stewart@variety.com